These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27589880)

  • 1. Breast Cancer in a 19-Year-Old Female Adolescent Identified with Li-Fraumeni Syndrome.
    Jay AM; Hamame AS; Dul C; Wesen C
    J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):e5-e6. PubMed ID: 27589880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR-mutated lung cancer in Li-Fraumeni syndrome.
    Michalarea V; Calcasola M; Cane P; Tobal K; Izatt L; Spicer J
    Lung Cancer; 2014 Sep; 85(3):485-7. PubMed ID: 25047674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiosarcoma in previously irradiated breast in patient with Li-Fraumeni syndrome. A case report.
    Barbosa OV; Reiriz AB; Boff RA; Oliveira WP; Rossi L
    Sao Paulo Med J; 2015; 133(2):151-3. PubMed ID: 25271877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A young woman with bilateral breast cancer: identifying a genetic cause and implications for management.
    de Bruin MA; Ford JM; Kurian AW
    J Natl Compr Canc Netw; 2013 May; 11(5):512-7. PubMed ID: 23667202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chest wall leiomyosarcoma after breast-conservative therapy for early-stage breast cancer in a young woman with Li-Fraumeni syndrome.
    Henry E; Villalobos V; Million L; Jensen KC; West R; Ganjoo K; Lebensohn A; Ford JM; Telli ML
    J Natl Compr Canc Netw; 2012 Aug; 10(8):939-42. PubMed ID: 22878818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
    Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
    Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Li-Fraumeni syndrome].
    Alonso-Cerezo MC; Pérez-Pérez P
    Med Clin (Barc); 2011 Oct; 137(9):425-6. PubMed ID: 21345471
    [No Abstract]   [Full Text] [Related]  

  • 8. The first documentation of Li-Fraumeni syndrome in Korea.
    Bang YJ; Kang SH; Kim TY; Jung CW; Oh SM; Choe KJ; Kim NK
    J Korean Med Sci; 1995 Jun; 10(3):205-10. PubMed ID: 8527048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecular signature of normal breast epithelial and stromal cells from Li-Fraumeni syndrome mutation carriers.
    Herbert BS; Chanoux RA; Liu Y; Baenziger PH; Goswami CP; McClintick JN; Edenberg HJ; Pennington RE; Lipkin SM; Kopelovich L
    Oncotarget; 2010 Oct; 1(6):405-422. PubMed ID: 21311097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome.
    Piao J; Sakurai N; Iwamoto S; Nishioka J; Nakatani K; Komada Y; Mizutani S; Takagi M
    Mol Carcinog; 2013 Oct; 52(10):770-6. PubMed ID: 22495821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohort.
    Mai PL; Khincha PP; Loud JT; DeCastro RM; Bremer RC; Peters JA; Liu CY; Bluemke DA; Malayeri AA; Savage SA
    JAMA Oncol; 2017 Dec; 3(12):1640-1645. PubMed ID: 28772286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile.
    Franceschi S; Spugnesi L; Aretini P; Lessi F; Scarpitta R; Galli A; Congregati C; Caligo MA; Mazzanti CM
    Carcinogenesis; 2017 Sep; 38(9):938-943. PubMed ID: 28911001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Li-Fraumeni syndrome].
    Sejben A; Tiszlavicz L; Polyák K; Kovács L; Maráz A; Török D; Leprán Á; Ottlakán A; Furák J
    Orv Hetil; 2019 Feb; 160(6):228-234. PubMed ID: 30730202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Li-Fraumeni syndrome.
    Ossa CA; Molina G; Cock-Rada AM
    Biomedica; 2016 Jun; 36(2):182-7. PubMed ID: 27622479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of Advexin: a p53 gene-replacement therapy in Li-Fraumeni syndrome.
    Nemunaitis JM; Nemunaitis J
    Future Oncol; 2008 Dec; 4(6):759-68. PubMed ID: 19086841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Li-Fraumeni syndrome].
    Frebourg T
    Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Li-Fraumeni syndrome and the p53 gene].
    Thoresen SO
    Tidsskr Nor Laegeforen; 1992 Mar; 112(7):887-9. PubMed ID: 1557756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benefit and burden of cancer screening in Li-Fraumeni syndrome: a case report.
    Jhaveri AP; Bale A; Lovick N; Zuckerman K; Deshpande H; Rath K; Schwartz P; Hofstatter EW
    Yale J Biol Med; 2015 Jun; 88(2):181-5. PubMed ID: 26029016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.